Return on Investment | GenomeWeb

Return on Investment

In a recent letter to Nature, the Mayo Clinic's Matthew Kumar says that since researchers use taxpayers' money to fund their research, researchers have an "obligation to reduce waste and inefficiency and to work within their means." NIH, unlike companies, does not get a good return on its investment in science, he says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.